pharma news today glp-1 obesity drug Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Obesity Drug Market Forecasts Downgraded
Description
Exhibit 247 of our 2025 pharmacy/PBM report highlights 18 brand-name drugs for which manufacturers lowered the list prices of marketed products
Levodopa offers significant benefits in motor function, independence, quality of life, and lifespan
10.1056/nejm199205143262003
William Blair may or may not own any securities of the issuers referenced and, if such securities are owned, no representation is being made that such securities will continue to be held
But the timeline is moving later than originally hoped
Large self-funded employers have even more flexibility to customize their benefit designs independent of the insurer default coverage terms
